Therapeutic applications of implantable drug delivery systems
Abstract
In the past, drugs were frequently administered orally, as liquids or in powder forms. To avoid problems incurred through the utilization of the oral route of drug administration, new dosage forms containing the drug(s) were introduced. As time progressed, there was a need for delivery systems that could maintain a steady release of drug to the specific site of action. Therefore, drug delivery systems were developed to optimize the therapeutic properties of drug products and render them more safe, effective, and reliable. Implantable drug delivery systems (IDDS) are an example of such systems available for therapeutic use. The application of currently available implantable drug delivery systems is the main focus of this review. IDDS can be classified into three major categories: biodegradable or nonbiodegradable implants, implantable pump systems, and the newest atypical class of implants. Biodegradable and nonbiodegradable implants are available as monolithic systems or reservoir systems. The release kinetics of drugs from such systems depend on both the solubility and diffusion coefficient of the drug in the polymer, the drug load, as well as the in vivo degradation rate of the polymer, especially, in the case of the biodegradable systems. Controlled release of drug from the implantable pump is generally achieved utilizing the microtechnology of electronic systems and remote-controlled flow rate manipulation through the maintenance of a constant pressure difference. The thi…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There are now a number of clinically accepted therapies relying on direct pumping of therapeutics into the CSF.
“however, there are now a number of clinically accepted therapies relying on direct pumping of therapeutics into the CSF.32,33”
From Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain (2013) · cites this paper as [32]
The citation lists haven’t been fetched yet
References 48 · Cited by 358
- Authors
- Dash, A., & Cudworth, G.
- Venue
- Journal of Pharmacological and Toxicological Methods
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 40
- Issue
- 1
- Pages
- 1-12
- ISSN
- 1056-8719 (ISSN-L)
- OpenAlex
- W1988250258
- Cited by
- 358
- References
- 48
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 14 · 2023: 18 · 2022: 10 · 2021: 13 · 2020: 16 · 2019: 15 · 2018: 13 · 2017: 12 · 2016: 18 · 2015: 17 · 2014: 16 · 2013: 21 · 2012: 25
- FWCI
- 0.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacological and Toxicological Methods (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- implantable drug delivery, controlled drug release, biodegradable implants, implantable pump, sustained drug release, drug release kinetics, bone infection, intraocular implants, glaucoma, erectile dysfunction, benefit-cost ratio, local drug delivery, polymer degradation
- MeSH terms
- Animals, Biodegradation, Environmental, Excipients, Humans, Infusion Pumps, Implantable
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review